Rocket


Overview
Financials
News + Filings


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

NUGENEREX IMMUNO-ONCOLOGY, INC. Create: Alert

All | News | Filings
Date FiledTypeDescription
07/23/2021 8-K Other Events
04/27/2021 8-K Quarterly results
02/10/2021 8-K Quarterly results
02/02/2021 8-K Quarterly results
01/08/2021 8-K Quarterly results
12/17/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "The Extension Agreement signed December 15, 2020"
11/25/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "INDEMNITY",
"INDEMNITY"
11/19/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "The Ii-Key Innovative Flu Vaccine Development Agreement signed November 13, 2020",
"Generex signs Worldwide Licensing Deal with China Partners on the Development of an Ii-Key-H1 Swine Influenza Vaccine"
11/18/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "The Ii-Key Innovative Vaccine Development Agreement signed November 13, 2020",
"Generex Inks $50 Million Licensing Deal with China Partners on the Cooperative Development of the Ii-Key Vaccine Platform"
11/05/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Framework Agreement on Cooperative Development of Coronavirus Peptide Vaccine signed October 30, 2020",
"Generex Announces the Signing of a Framework Agreement with The China CDC, Beijing Guoxin Haixiang Equity Investment Partnership and Beijing Youfeng International Consulting Co., Ltd on the Cooperative Development of Ii-Key Vaccines"
10/14/2020 8-K Quarterly results
07/20/2020 8-K Quarterly results
06/23/2020 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy